Home Factors affecting community pharmacist’s service for women with chronic diseases during pregnancy and breastfeeding: application of the Health Belief Model
Article
Licensed
Unlicensed Requires Authentication

Factors affecting community pharmacist’s service for women with chronic diseases during pregnancy and breastfeeding: application of the Health Belief Model

  • Septi Anggraini , Wahyu Utami and Elida Zairina EMAIL logo
Published/Copyright: December 19, 2019

Abstract

Background

Pharmacists are known as health care professionals who are responsible for the safety and efficacy of medicine to achieve optimal therapeutic results. Community pharmacists have an opportunity to provide direct services including giving an active medication information service in women during pregnancy and breastfeeding. This study aimed to determine the factors associated with the practice of community pharmacists for actively giving the drug information service for women with chronic diseases during pregnancy and breastfeeding based on the Health Belief Model.

Methods

About 300 community pharmacists were randomly chosen to participate in the study. All participants were asked to complete questionnaires that were designed based on the theory of the Health Belief Models. The questionnaires measured the community pharmacists’ knowledge, beliefs, cues to action, and practice for actively giving medication information services.

Results

About 267 pharmacists in the community agreed to participate in this study. Nearly 80% of the participants were female pharmacists (n = 213). The results show that pharmacists’ knowledge had significant influences towards perceived threat (p = 0.009), perceived benefit (p = 0.011), and pharmacists’ self-efficacy (p < 0.001). The self-efficacy factor was the most influential factor in the practice of pharmacists to give medication information service actively (p < 0.001).

Conclusions

The findings of the study indicate that self-efficacy is the most important factor for pharmacist to be able to provide the medication information services successfully particularly in women during pregnancy and breastfeeding. Providing continuous learning programs through seminars and training related to medication use during pregnancy and breastfeeding to pharmacists is needed to optimise the confidence and the ability of pharmacists in providing the services.

Acknowledgment

We thank the Public Health Office of Surabaya for the permission to conduct research at Primary Healthcare Centres in Surabaya. Also, we would like to thank all pharmacists who participated in this study. We thank the Directorate of Higher Degree in Indonesia for funding this study. This paper has been presented at the 8th APPEN Conference and the 2nd HPC Conference on 8-9 October 2019, Universitas Airlangga, Surabaya, Indonesia.

  1. Research funding: This study is supported by Directorate of Higher Degree in Indonesia for funding this study through Penelitian Tesis Magister scheme.

  2. Author contributions: All authors have accepted responsibility for the entire content of this manuscript and approved its submission.

  3. Competing interests: Authors state no conflict of interest.

  4. Informed consent: Informed consent was obtained from all individuals included in this study.

  5. Ethical approval: Research involving human subjects complied with all relevant national regulations, institutional policies and is in accordance with the tenets of the Helsinki Declaration (as revised in 2013), and has been approved by the Human Research Ethics Committee of Faculty of Public Health Universitas Airlangga review board (56/EA/KEPK/2019).

References

[1] Pigarelli DL, Kraus CK, Potter BE. Pregnancy and breastfeeding: therapeutic consideration. In: Dipiro JT, Talbert RL, Yee GC, Matzke GR, Wells BG, Posey LM, editors. Pharmacotherapy: a pathopysiologic approach, 7th ed. New York: The McGraw-Hill Companies Inc., 2008:1297–300.Search in Google Scholar

[2] Montagne M, McCarthy RL. Ethics and professionalism. In: Troy D, editor. Remington: the science and practice of pharmacy, 21st ed. Philadelphia: Lippincott Williams and Wilkins, 2005:23.Search in Google Scholar

[3] Rikomah SE. Farmasi Klinik Edisi 1. Yogyakarta: Deepublish, 2016.Search in Google Scholar

[4] Baroroh F. Evaluasi Kepuasan Konsumen terhadap Pelayanan Kefarmasian di Apotek Kota Yogyakarta. Pharmaciana 2014;4:135–41.10.12928/pharmaciana.v4i2.1570Search in Google Scholar

[5] Mayefis D, Halim A, Rahim R. Pengaruh Kualitas Pelayanan Informasi Obat terhadap Kepuasan Pasien Apotek X Kota Padang. Jurnal Ilmu Kefarmasian Indonesia 2015;13:201–4.Search in Google Scholar

[6] Athiyah U, Riskayanti E, Rakhmawati FD, Nugraheni G, Nita Y. Profil Informasi Obat Pada Pelayanan Resep Metformin dan Glibenklamid di Apotek di Wilayah Surabaya. Jurnal Farmasi Komunitas 2014;1:5–10.Search in Google Scholar

[7] Harlianti MS, Andayani TM, Puspandari DA. Pengaruh Kepuasan Terhadap Kemauan Membayar (Willingness to Pay) Jasa Pelayanan Konseling oleh Apoteker di Apotek. Jurnal Ilmiah Farmasi 2016;4:26–30.10.26874/kjif.v4i1.54Search in Google Scholar

[8] Muharni S, Aryani F, Mizanni M. Gambaran Tenaga Kefarmasian dalam Memberikan Informasi kepada Pelaku Swamedikasi di Apotek-apotek Kecamatan Tampan Pekanbaru. Jurnal Sains Farmasi dan Klinis 2015;2:47–53.10.29208/jsfk.2015.2.1.46Search in Google Scholar

[9] Boonyaprapa S. Self-care in pregnancy and breastfeeding: views of women and community pharmacists in Thailand [dissertation]. England: University of Nottingham, 2010.Search in Google Scholar

[10] Damayanti R. Persepsi dalam Promosi Kesehatan. In: Notoatmodjo S, editor. Promosi Kesehatan Teori dan Aplikasinya. Jakarta: Rineka Cipta, 2018:105–6.Search in Google Scholar

[11] Sadasivam K, Chinnasami B, Ramraj B, Karthick N, Saravanan A. Knowledge, attitude and practice of paramedical staff towards antibiotic usage and its resistance. Biomed Pharmacol J 2016;9:337–43.10.13005/bpj/944Search in Google Scholar

[12] Champion VL, Skinner CS. The health belief model. In: Glanz K, Rimer BK, Viswanath K, editors. Health behavior and health education: theory, research and practice. San Francisco: John Wiley and Sons, Inc., 2008:48.Search in Google Scholar

[13] Hermansyah A, Sainsbury E, Krass I. Investigating the impact of the universal healthcare coverage programme on community pharmacy practice. Health Soc Care Commun 2017;1:1–12.10.1111/hsc.12506Search in Google Scholar PubMed

[14] Zerafa N, Scerri C. Knowledge and pharmacological management of Alzheimer’s disease by managing community pharmacists: a nationwide study. Int J Clin Pharm 2016;38:1416–24.10.1007/s11096-016-0380-8Search in Google Scholar PubMed

Received: 2019-11-17
Accepted: 2019-11-18
Published Online: 2019-12-19

© 2019 Walter de Gruyter GmbH, Berlin/Boston

Articles in the same Issue

  1. Reviews
  2. Pharmacist contributions in the treatment of diabetes mellitus in Southeast Asia: a narrative review
  3. The implementation of a chronic disease management program (Prolanis) in Indonesia: a literature review
  4. Original Articles
  5. Quercetin attenuates acute predator stress exposure-evoked innate fear and behavioral perturbation
  6. Evaluating current practices and policies in the use of injectable medicines for treating myalgia in a primary care center in Pamekasan, Indonesia
  7. The contemporary role and potential of pharmacist contribution for community health using social media
  8. Evaluation of rational drug use based on World Health Organization prescribing indicators in a primary care center in Pamekasan East Java, Indonesia
  9. The prescription patterns of second-generation antipsychotics in schizophrenia outpatient setting
  10. Factors affecting community pharmacist’s service for women with chronic diseases during pregnancy and breastfeeding: application of the Health Belief Model
  11. Overview of therapeutic changes in antiepileptic drugs in adult patients
  12. Exploration of barriers affecting job satisfaction among community pharmacists
  13. Patients’ characteristics and their adherence to insulin therapy
  14. Correlation of chemotherapy costs with quality of life in nasopharyngeal cancer patients
  15. Impact of educational preeclampsia prevention booklet on knowledge and adherence to low dose aspirin among pregnant women with high risk for preeclampsia
  16. Translation, cultural adaptation, and validation of the quality of well being self-administered questionnaire in general population in Indonesia
  17. Knowledge, attitude, and practice of pharmacists towards management of hypertension in primary care centers
  18. Medication adherence in diabetes mellitus patients at Tanjung Karang Primary Health Care Center, Mataram
  19. Decreasing angiogenesis vasa vasorum through Lp-PLA2 and H2O2 inhibition by PSP from Ganoderma lucidum in atherosclerosis: in vivo diabetes mellitus type 2
  20. Antiaggregation effect of clopidogrel in coronary heart disease patients using omeprazole
  21. The effect of curcuma (Curcuma xanthorrizha roxb.) extract as an adjuvant of captopril therapy on cardiac histopathology of male mice (Mus musculus) with hypertension
  22. Coenzyme Q10 nanostructured lipid carriers as an inducer of the skin fibroblast cell and its irritability test in a mice model
  23. Medical problems in patients with chronic kidney disease undergoing hemodialysis and their therapy
  24. ADMET properties of novel 5-O-benzoylpinostrobin derivatives
  25. Development of nonalcoholic fatty liver disease model by high-fat diet in rats
  26. Molecular docking of novel 5-O-benzoylpinostrobin derivatives as wild type and L858R/T790M/V948R mutant EGFR inhibitor
  27. The relationship between the level of education and accuracy of insulin injection techniques in DM patients with measurement of HbA1c values
  28. The effect of premixed insulin to blood glucose concentration in patients with type 2 diabetes mellitus
  29. Intravenous insulin therapy in diabetes mellitus with hyperglycemic crisis and intercurrent illness
  30. Adherence behavior assessment of oral antidiabetic medication use: a study of patient decisions in long-term disease management in primary health care centers in Surabaya
  31. Evaluation to the chemotherapy use in patients with diffuse large B-cell lymphoma
  32. Analysis of the use and cost of stress ulcer prophylaxis for surgical inpatients
  33. Antineuroinflammation activity of n-butanol fraction of Marsilea crenata Presl. in microglia HMC3 cell line
  34. The enhancement of Arg1 and activated ERβ expression in microglia HMC3 by induction of 96% ethanol extract of Marsilea crenata Presl. leaves
  35. Ternary solid dispersion to improve solubility and dissolution of meloxicam
  36. Improving solubility and dissolution of meloxicam by solid dispersion using hydroxypropyl methylcellulose 2910 3 cps and nicotinamide
  37. o-Hydroxycinnamic derivatives as prospective anti-platelet candidates: in silico pharmacokinetic screening and evaluation of their binding sites on COX-1 and P2Y12 receptors
  38. The change of proinflammatory cytokine tumor necrosis factor α level in the use of meloxicam in rat model of osteoarthritis
  39. Attenuation of IL-1ß on the use of glucosamine as an adjuvant in meloxicam treatment in rat models with osteoarthritis
  40. Analysis of effectiveness and drug related problems of pain reliever for knee osteoarthritis: weighing clinical risk and benefit
  41. Comparison of antibiotic prescriptions in adults and children with upper respiratory tract infections in Bangka Tengah primary health care centers
  42. Profile of sociodemographics, sources of infection, antiretrovirals and CD4 counts on HIV/AIDS outpatients in Turen Primary Health Centre, Indonesia
  43. Synergistic anti-hepatitis C virus activity of Ruta angustifolia extract with NS3 protein inhibitor
  44. In vitro equivalence of generic and branded amoxicillin tablet by microbiological assay method
  45. Knowledge and attitude: two fundamental factors that determine patient compliance in antibiotic therapy
  46. Molecular docking study of sappan wood extract to inhibit PBP2A enzyme on methicillin-resistant Staphylococcus aureus (MRSA)
  47. Effect of curcumin analogue synthetic product from cullilawan oil for the liver damage treatment in male mice (Mus musculus L.)
  48. Case Report
  49. A case report of generalized tetanus in a 42-year-old man with dental infection
Downloaded on 9.9.2025 from https://www.degruyterbrill.com/document/doi/10.1515/jbcpp-2019-0347/html
Scroll to top button